Crossmark

18F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after initial definitive treatment

Crossref DOI link: https://doi.org/10.1007/s10147-026-02958-8

Published Online: 2026-01-16

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Murata, Shiori https://orcid.org/0000-0001-5791-6624
Moribata, Yusaku

Akamatsu, Shusuke

Kido, Aki

Himoto, Yuki

Kurata, Yasuhisa

Otani, Tomoaki

Sumiyoshi, Takayuki

Saito, Ryoichi

Ogata, Takashi

Aizawa, Rihito

Nakamura, Kiyonao

Mizowaki, Takashi

Nakamoto, Yuji

Kobayashi, Takashi

Goto, Takayuki
License Information

Text and Data Mining valid from 2026-01-16

Version of Record valid from 2026-01-16
More Information

Article History

Received: 7 October 2025

Accepted: 3 January 2026

First Online: 16 January 2026

Declarations

:

: The authors have no conflict of interest.

Document is current

Any future updates will be listed below